Intellectual Property Magazine

Diamond Therapeutics adds Nancy Raimondi as IP director

Canadian drug development company Diamond Therapeutics hashired Nancy Raimondi as its new director of intellectual property (IP).

The rest of this document is only available to i-law.com online subscribers.

If you are already a subscriber, click Log In button.